CMS: Agency Information Collection Activities: Submission for OMB Review; Comment Request

Federal Register

Nov 5, 2026

Notice from the Centers for Medicare & Medicaid Services (CMS) seeking comments on the following information collections: 1) Collection Requirements for Compendia for Determination of Medically-accepted Indications for Off-label Uses of Drugs and Biologicals in an Anti-cancer Chemotherapeutic Regimen; 2) Quality Bonus Payment Appeals; and 3) The In-Center Hemodialysis Consumer Assessment of Healthcare Providers and Systems Survey Mode Experiment. Comments are due by December 7, 2026.

Healthcare quality · Medicare · Pharmacy and prescription drugs · Policy